ArticleCureus2026
The Role of Antibody Testing and Vaccination in Paediatric Recurrent Acute Otitis Media.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRecurrent acute otitis media (RAOM) is a common condition most frequently affecting children under two years of age. The main causative agent is
methodA retrospective study was performed between January and December 2023. A total of 1,004 paediatric referrals (age: ≤ 16 years) to our trust were reviewed. Patients with RAOM who underwent pneumococcal antibody testing were identified. Suboptimal antibody levels were defined as ≥ 6 low serotypes out of 13. This study took place at Royal Preston Hospital, United Kingdom.
resultsOur cohort includes 169 children with RAOM, of which 42 underwent pneumococcal antibody testing with available results. Of these patients, 19 (45.2%) had suboptimal pneumococcal antibody levels; 13 (68.4%) patients received a booster vaccine. A reduction in RAOM episodes was reported in 92.3% (12/13) of vaccinated children at follow-up (≥ 3 months), with improvement in symptoms, including otalgia, fever, and hearing loss. Adequate
conclusionThese findings indicate that approximately half of children with RAOM have suboptimal pneumococcal antibody levels, which can be successfully addressed with booster vaccination. Re-testing pneumococcal antibody levels after booster vaccination and performing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.